Other Clinical Trial - ivWatch Model 400: Device Validation for

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Infiltration of Peripheral IV Therapy

See also
Status	Clinical Trial	Phase
Completed	`NCT02123745` - ivWatch Model 400: Device Validation for Infiltrated Tissues	N/A
Completed	`NCT02553421` - Optical Detection of Intravenous Infiltration:A Pilot Study	N/A
Completed	`NCT04064229` - ivWatch Sensor: Device Validation for Infiltrated Tissues	N/A
Completed	`NCT04065373` - ivWatch SmartTouch Sensor: Device Validation for Non-Infiltrated Tissues	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT02123745 - ivWatch Model 400: Device Validation for Infiltrated Tissues

N/A

Completed

NCT02553421 - Optical Detection of Intravenous Infiltration:A Pilot Study

N/A

Completed

NCT04064229 - ivWatch Sensor: Device Validation for Infiltrated Tissues

N/A

Completed

NCT04065373 - ivWatch SmartTouch Sensor: Device Validation for Non-Infiltrated Tissues

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02120443
Study type	Interventional
Source	ivWatch, LLC
Contact
Status	Completed
Phase	N/A
Start date	January 2014
Completion date	January 2014

ivWatch Model 400: Device Validation for Non-Infiltrated Tissues

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms